

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.58232790 |
| 2 | DNA deamination (GO:0045006) | 6.34698297 |
| 3 | viral transcription (GO:0019083) | 6.19602293 |
| 4 | translational termination (GO:0006415) | 6.00560595 |
| 5 | translational elongation (GO:0006414) | 5.48308982 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 5.27069687 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.26753709 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.13662670 |
| 9 | protein targeting to ER (GO:0045047) | 5.12931879 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 5.03956910 |
| 11 | translational initiation (GO:0006413) | 4.99184323 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.94940445 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.84699463 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.84550120 |
| 15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.83734597 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 4.79669528 |
| 17 | viral life cycle (GO:0019058) | 4.74839733 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.70286477 |
| 19 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.37767511 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.29486474 |
| 21 | protein complex disassembly (GO:0043241) | 4.24848769 |
| 22 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.23536867 |
| 23 | translation (GO:0006412) | 4.18533403 |
| 24 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.18301300 |
| 25 | DNA strand elongation (GO:0022616) | 4.11740777 |
| 26 | macromolecular complex disassembly (GO:0032984) | 4.07430320 |
| 27 | GDP-mannose metabolic process (GO:0019673) | 4.00570565 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99092139 |
| 29 | protein maturation by protein folding (GO:0022417) | 3.97952068 |
| 30 | proteasome assembly (GO:0043248) | 3.81203804 |
| 31 | DNA replication initiation (GO:0006270) | 3.75015477 |
| 32 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.74029872 |
| 33 | ribosome biogenesis (GO:0042254) | 3.72968869 |
| 34 | DNA unwinding involved in DNA replication (GO:0006268) | 3.65198833 |
| 35 | pseudouridine synthesis (GO:0001522) | 3.64398850 |
| 36 | UV protection (GO:0009650) | 3.62430236 |
| 37 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.62382609 |
| 38 | telomere maintenance via recombination (GO:0000722) | 3.59036827 |
| 39 | DNA replication checkpoint (GO:0000076) | 3.55224288 |
| 40 | rRNA processing (GO:0006364) | 3.54668353 |
| 41 | pinocytosis (GO:0006907) | 3.53971928 |
| 42 | mature B cell differentiation involved in immune response (GO:0002313) | 3.52383346 |
| 43 | mRNA catabolic process (GO:0006402) | 3.52295350 |
| 44 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.50385803 |
| 45 | cellular component biogenesis (GO:0044085) | 3.49675125 |
| 46 | spliceosomal snRNP assembly (GO:0000387) | 3.49362232 |
| 47 | RNA catabolic process (GO:0006401) | 3.44986309 |
| 48 | rRNA metabolic process (GO:0016072) | 3.43730878 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.41576533 |
| 50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40803249 |
| 51 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.40606523 |
| 52 | establishment of integrated proviral latency (GO:0075713) | 3.37587495 |
| 53 | nucleobase biosynthetic process (GO:0046112) | 3.34868841 |
| 54 | protein targeting to membrane (GO:0006612) | 3.33891423 |
| 55 | barbed-end actin filament capping (GO:0051016) | 3.30417771 |
| 56 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.30285919 |
| 57 | ATP synthesis coupled proton transport (GO:0015986) | 3.30285919 |
| 58 | mitotic recombination (GO:0006312) | 3.26897909 |
| 59 | telomere maintenance via telomere lengthening (GO:0010833) | 3.24539241 |
| 60 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.24100630 |
| 61 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.23583738 |
| 62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.22505955 |
| 63 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.22395386 |
| 64 | negative regulation of ligase activity (GO:0051352) | 3.22395386 |
| 65 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.21984417 |
| 66 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20752325 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.20497467 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 3.18435081 |
| 69 | protein localization to kinetochore (GO:0034501) | 3.15657571 |
| 70 | purine nucleobase biosynthetic process (GO:0009113) | 3.14584681 |
| 71 | regulation of mitochondrial translation (GO:0070129) | 3.14145108 |
| 72 | mannose metabolic process (GO:0006013) | 3.12430358 |
| 73 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.11178470 |
| 74 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.10916071 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10246868 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.09890463 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 3.09890463 |
| 78 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.09062238 |
| 79 | NADH metabolic process (GO:0006734) | 3.07574265 |
| 80 | immunoglobulin mediated immune response (GO:0016064) | 3.07466330 |
| 81 | viral mRNA export from host cell nucleus (GO:0046784) | 3.06948097 |
| 82 | protein retention in ER lumen (GO:0006621) | 3.06012985 |
| 83 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.05017972 |
| 84 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.05017972 |
| 85 | negative regulation of RNA splicing (GO:0033119) | 3.04831982 |
| 86 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.03308082 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.03308082 |
| 88 | oxidative phosphorylation (GO:0006119) | 3.02087282 |
| 89 | deoxyribonucleotide catabolic process (GO:0009264) | 3.01465388 |
| 90 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.01116785 |
| 91 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99808815 |
| 92 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99808815 |
| 93 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99808815 |
| 94 | pentose-phosphate shunt (GO:0006098) | 2.97643236 |
| 95 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.95899314 |
| 96 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.95723632 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.94710990 |
| 98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94599880 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94599880 |
| 100 | nucleotide salvage (GO:0043173) | 2.93953185 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93834205 |
| 102 | negative regulation of cell size (GO:0045792) | 2.93295508 |
| 103 | regulation of necrotic cell death (GO:0010939) | 2.92806762 |
| 104 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.92689237 |
| 105 | ribosome assembly (GO:0042255) | 2.92264274 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.92243621 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 2.91577809 |
| 108 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.90239691 |
| 109 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.87731067 |
| 110 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.86821359 |
| 111 | rRNA modification (GO:0000154) | 2.86816289 |
| 112 | deoxyribose phosphate catabolic process (GO:0046386) | 2.86336056 |
| 113 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85979102 |
| 114 | spliceosomal complex assembly (GO:0000245) | 2.85639361 |
| 115 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.85384811 |
| 116 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.84907235 |
| 117 | termination of RNA polymerase II transcription (GO:0006369) | 2.84892338 |
| 118 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.84787754 |
| 119 | response to peptidoglycan (GO:0032494) | 2.84493228 |
| 120 | negative regulation of B cell apoptotic process (GO:0002903) | 2.83398185 |
| 121 | mitotic metaphase plate congression (GO:0007080) | 2.83218869 |
| 122 | metallo-sulfur cluster assembly (GO:0031163) | 2.82980726 |
| 123 | iron-sulfur cluster assembly (GO:0016226) | 2.82980726 |
| 124 | UTP biosynthetic process (GO:0006228) | 2.82456477 |
| 125 | IMP biosynthetic process (GO:0006188) | 2.82437984 |
| 126 | CENP-A containing nucleosome assembly (GO:0034080) | 2.81653320 |
| 127 | chromatin remodeling at centromere (GO:0031055) | 2.81543171 |
| 128 | establishment of protein localization to mitochondrion (GO:0072655) | 2.81125576 |
| 129 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.80674977 |
| 130 | protein targeting to mitochondrion (GO:0006626) | 2.79951220 |
| 131 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.77991195 |
| 132 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.73524001 |
| 133 | glucose catabolic process (GO:0006007) | 2.70180676 |
| 134 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.68601640 |
| 135 | COPI coating of Golgi vesicle (GO:0048205) | 2.65567867 |
| 136 | Golgi transport vesicle coating (GO:0048200) | 2.65567867 |
| 137 | proline biosynthetic process (GO:0006561) | 2.65496771 |
| 138 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64323073 |
| 139 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.64303284 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.57717399 |
| 141 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.57322053 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55416464 |
| 143 | regulation of mitochondrial membrane potential (GO:0051881) | 2.53509595 |
| 144 | negative regulation of necroptotic process (GO:0060546) | 2.53111539 |
| 145 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52203146 |
| 146 | purine nucleotide salvage (GO:0032261) | 2.50427376 |
| 147 | modulation by virus of host process (GO:0019054) | 2.49948834 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.48540703 |
| 149 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.45837533 |
| 150 | thymic T cell selection (GO:0045061) | 2.44268470 |
| 151 | actin nucleation (GO:0045010) | 2.42835135 |
| 152 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.41387892 |
| 153 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.39226328 |
| 154 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.38434341 |
| 155 | mature B cell differentiation (GO:0002335) | 2.37711791 |
| 156 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.36506361 |
| 157 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.35158250 |
| 158 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.33945473 |
| 159 | NADPH regeneration (GO:0006740) | 2.33747741 |
| 160 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32729265 |
| 161 | negative regulation of phagocytosis (GO:0050765) | 2.32611939 |
| 162 | pyrimidine-containing compound salvage (GO:0008655) | 2.32513986 |
| 163 | pyrimidine nucleoside salvage (GO:0043097) | 2.32513986 |
| 164 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30920304 |
| 165 | activation of MAPKKK activity (GO:0000185) | 2.30582203 |
| 166 | regulation of monocyte differentiation (GO:0045655) | 2.29849356 |
| 167 | deoxyribose phosphate metabolic process (GO:0019692) | 2.28674044 |
| 168 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.28642688 |
| 169 | Peyers patch development (GO:0048541) | 2.28642688 |
| 170 | tricarboxylic acid metabolic process (GO:0072350) | 2.27381900 |
| 171 | negative regulation of necrotic cell death (GO:0060547) | 2.24718179 |
| 172 | detection of bacterium (GO:0016045) | 2.23673120 |
| 173 | response to interferon-beta (GO:0035456) | 2.23473239 |
| 174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21543224 |
| 175 | prostanoid biosynthetic process (GO:0046457) | 2.20611121 |
| 176 | prostaglandin biosynthetic process (GO:0001516) | 2.20611121 |
| 177 | apoptotic process involved in morphogenesis (GO:0060561) | 2.19593398 |
| 178 | oxaloacetate metabolic process (GO:0006107) | 2.19318106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.37882044 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.37622880 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.30868513 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.09046845 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.07136980 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05867513 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.02768059 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02673871 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.01409374 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99683442 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.86118644 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74613917 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.72656154 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.68460471 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.61504937 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.60484706 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.56728482 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.56174581 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.50936639 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.49910431 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.43676829 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41920375 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20656907 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.16895626 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.15343451 |
| 26 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13045470 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.07873594 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07284267 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05910567 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04832954 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.03030302 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.02412595 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.02055752 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00941345 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.00769909 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.98210902 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96183550 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.91764736 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.89574651 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.84677292 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84590705 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81424379 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78737967 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76528390 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72319811 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70695747 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68635274 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67833489 |
| 49 | * P68_20966046_ChIP-Seq_HELA_Human | 1.67227742 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64474492 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.62769399 |
| 52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61637109 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.57567765 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56724605 |
| 55 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54563751 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54044945 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52155648 |
| 58 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50569424 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50536799 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.50098489 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49266045 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47829626 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45480178 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.44493500 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.44448836 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.44421330 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44344490 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42838188 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42316894 |
| 70 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42138605 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41085941 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40524140 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40460716 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36789674 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36143216 |
| 76 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35684737 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34532592 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33760006 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33402474 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32243395 |
| 81 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31270024 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30693815 |
| 83 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.29546810 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29432309 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29093746 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28972164 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28617360 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27304087 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27146606 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25580042 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24669441 |
| 92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21654332 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21593013 |
| 94 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21346152 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20900644 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20137433 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19176873 |
| 98 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19005165 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18119880 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15997352 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15139679 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14803382 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13896347 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13286543 |
| 105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13196023 |
| 106 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12693620 |
| 107 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12582254 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12471412 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11783992 |
| 110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11401335 |
| 111 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.10454615 |
| 112 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10327861 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09957412 |
| 114 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.09766180 |
| 115 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08975544 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08929445 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08723030 |
| 118 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08699301 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08665031 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07862886 |
| 121 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05422591 |
| 122 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05209110 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04719055 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04075131 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03793658 |
| 126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03787650 |
| 127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03526517 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03354549 |
| 129 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03123928 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02399038 |
| 131 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02264239 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00576930 |
| 133 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00034804 |
| 134 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99848424 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99466684 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97010225 |
| 137 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96730124 |
| 138 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96474648 |
| 139 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.95478333 |
| 140 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95348408 |
| 141 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.95035014 |
| 142 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93631797 |
| 143 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.92632894 |
| 144 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91662333 |
| 145 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90946032 |
| 146 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88986831 |
| 147 | * MAF_26560356_Chip-Seq_TH2_Human | 0.88415585 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87927313 |
| 149 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87916068 |
| 150 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.87635008 |
| 151 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87182277 |
| 152 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.85562049 |
| 153 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85363640 |
| 154 | MAF_26560356_Chip-Seq_TH1_Human | 0.84029978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.30713496 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.46591926 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.02456679 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.61978836 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.60174297 |
| 6 | MP0005451_abnormal_body_composition | 3.58561303 |
| 7 | MP0003077_abnormal_cell_cycle | 3.57008275 |
| 8 | MP0002396_abnormal_hematopoietic_system | 3.02741684 |
| 9 | MP0008058_abnormal_DNA_repair | 2.60909622 |
| 10 | MP0008057_abnormal_DNA_replication | 2.55334899 |
| 11 | MP0003303_peritoneal_inflammation | 2.41895069 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.38349487 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.32650097 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.26462172 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.25097462 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.21661495 |
| 17 | MP0000490_abnormal_crypts_of | 2.21533047 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.11182751 |
| 19 | MP0001730_embryonic_growth_arrest | 2.09381514 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.09138636 |
| 21 | MP0003186_abnormal_redox_activity | 1.99233057 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.98488865 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.93928856 |
| 24 | MP0003075_altered_response_to | 1.92456985 |
| 25 | MP0000350_abnormal_cell_proliferation | 1.86259716 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.85536235 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.85272967 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.84394502 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.84394502 |
| 30 | MP0008260_abnormal_autophagy | 1.79448389 |
| 31 | MP0000313_abnormal_cell_death | 1.79212665 |
| 32 | MP0002419_abnormal_innate_immunity | 1.79004372 |
| 33 | MP0005387_immune_system_phenotype | 1.74880700 |
| 34 | MP0001790_abnormal_immune_system | 1.74880700 |
| 35 | MP0003123_paternal_imprinting | 1.71613484 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.69347283 |
| 37 | MP0002398_abnormal_bone_marrow | 1.65945353 |
| 38 | MP0004510_myositis | 1.62476265 |
| 39 | MP0000685_abnormal_immune_system | 1.61418975 |
| 40 | MP0001849_ear_inflammation | 1.60451704 |
| 41 | MP0002019_abnormal_tumor_incidence | 1.59993440 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.57411725 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.57313097 |
| 44 | MP0002722_abnormal_immune_system | 1.56279654 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.54644135 |
| 46 | MP0001697_abnormal_embryo_size | 1.53156438 |
| 47 | MP0002080_prenatal_lethality | 1.52311312 |
| 48 | MP0005166_decreased_susceptibility_to | 1.50529712 |
| 49 | MP0000358_abnormal_cell_content/ | 1.50376755 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.45551068 |
| 51 | MP0000681_abnormal_thyroid_gland | 1.45028775 |
| 52 | MP0003786_premature_aging | 1.44931719 |
| 53 | MP0002132_abnormal_respiratory_system | 1.44369210 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.42084925 |
| 55 | MP0001853_heart_inflammation | 1.40845220 |
| 56 | MP0004858_abnormal_nervous_system | 1.38120615 |
| 57 | MP0002429_abnormal_blood_cell | 1.34828213 |
| 58 | MP0000343_altered_response_to | 1.32371979 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.32002633 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.31798570 |
| 61 | MP0005083_abnormal_biliary_tract | 1.31487886 |
| 62 | MP0005165_increased_susceptibility_to | 1.29216625 |
| 63 | MP0006082_CNS_inflammation | 1.28763473 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.27702252 |
| 65 | MP0005380_embryogenesis_phenotype | 1.26958961 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.26958961 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.26644191 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.24397001 |
| 69 | MP0004947_skin_inflammation | 1.23756822 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.23192309 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.22710751 |
| 72 | MP0000716_abnormal_immune_system | 1.22323626 |
| 73 | MP0005330_cardiomyopathy | 1.20540995 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20289116 |
| 75 | MP0003984_embryonic_growth_retardation | 1.17861519 |
| 76 | MP0001835_abnormal_antigen_presentation | 1.17722899 |
| 77 | MP0000858_altered_metastatic_potential | 1.17305437 |
| 78 | MP0005670_abnormal_white_adipose | 1.16833089 |
| 79 | MP0003718_maternal_effect | 1.15133882 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.14522025 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 1.14419745 |
| 82 | MP0009840_abnormal_foam_cell | 1.14038753 |
| 83 | MP0000751_myopathy | 1.10459346 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.09803329 |
| 85 | MP0003119_abnormal_digestive_system | 1.09205184 |
| 86 | MP0002653_abnormal_ependyma_morphology | 1.09112020 |
| 87 | MP0000747_muscle_weakness | 1.08884495 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.08551907 |
| 89 | MP0002139_abnormal_hepatobiliary_system | 1.07996571 |
| 90 | MP0003646_muscle_fatigue | 1.07684544 |
| 91 | MP0002085_abnormal_embryonic_tissue | 1.06530798 |
| 92 | MP0004133_heterotaxia | 1.05773634 |
| 93 | MP0001800_abnormal_humoral_immune | 1.05373773 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.04659524 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.04341225 |
| 96 | MP0000003_abnormal_adipose_tissue | 1.04325021 |
| 97 | MP0009278_abnormal_bone_marrow | 1.03904468 |
| 98 | MP0002420_abnormal_adaptive_immunity | 1.02867347 |
| 99 | MP0003724_increased_susceptibility_to | 1.02173217 |
| 100 | MP0002086_abnormal_extraembryonic_tissu | 1.00825590 |
| 101 | MP0001819_abnormal_immune_cell | 1.00776054 |
| 102 | MP0002405_respiratory_system_inflammati | 0.99063406 |
| 103 | MP0000759_abnormal_skeletal_muscle | 0.98296899 |
| 104 | MP0001764_abnormal_homeostasis | 0.98112797 |
| 105 | MP0005025_abnormal_response_to | 0.97915981 |
| 106 | MP0003436_decreased_susceptibility_to | 0.97831445 |
| 107 | MP0000604_amyloidosis | 0.95906854 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.93999862 |
| 109 | MP0005360_urolithiasis | 0.93984668 |
| 110 | MP0008877_abnormal_DNA_methylation | 0.93756010 |
| 111 | MP0005266_abnormal_metabolism | 0.93068665 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.92583371 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.92077959 |
| 114 | MP0003329_amyloid_beta_deposits | 0.91833533 |
| 115 | MP0009785_altered_susceptibility_to | 0.91640351 |
| 116 | MP0002723_abnormal_immune_serum | 0.91247019 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90432239 |
| 118 | MP0002452_abnormal_antigen_presenting | 0.89826730 |
| 119 | MP0005501_abnormal_skin_physiology | 0.89621427 |
| 120 | MP0002084_abnormal_developmental_patter | 0.88864910 |
| 121 | MP0005174_abnormal_tail_pigmentation | 0.88696835 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86759083 |
| 123 | MP0006054_spinal_hemorrhage | 0.85127490 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.82650535 |
| 125 | MP0002269_muscular_atrophy | 0.82633096 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.81557896 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.80757777 |
| 128 | MP0009764_decreased_sensitivity_to | 0.80175555 |
| 129 | MP0003279_aneurysm | 0.78911643 |
| 130 | MP0001661_extended_life_span | 0.78728684 |
| 131 | MP0005671_abnormal_response_to | 0.78183418 |
| 132 | MP0010155_abnormal_intestine_physiology | 0.77951722 |
| 133 | MP0010307_abnormal_tumor_latency | 0.77777169 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.77711274 |
| 135 | MP0000598_abnormal_liver_morphology | 0.76922275 |
| 136 | MP0004233_abnormal_muscle_weight | 0.75226463 |
| 137 | MP0004087_abnormal_muscle_fiber | 0.73670741 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.73655451 |
| 139 | MP0009672_abnormal_birth_weight | 0.73630173 |
| 140 | MP0002166_altered_tumor_susceptibility | 0.72683430 |
| 141 | MP0008874_decreased_physiological_sensi | 0.72647531 |
| 142 | MP0002160_abnormal_reproductive_system | 0.72308719 |
| 143 | MP0005384_cellular_phenotype | 0.72083284 |
| 144 | MP0002933_joint_inflammation | 0.70524958 |
| 145 | MP0009763_increased_sensitivity_to | 0.70466977 |
| 146 | MP0008469_abnormal_protein_level | 0.69223783 |
| 147 | MP0002796_impaired_skin_barrier | 0.68907094 |
| 148 | MP0003866_abnormal_defecation | 0.68341970 |
| 149 | MP0005023_abnormal_wound_healing | 0.66794399 |
| 150 | MP0005000_abnormal_immune_tolerance | 0.64815587 |
| 151 | MP0001348_abnormal_lacrimal_gland | 0.64788388 |
| 152 | MP0002751_abnormal_autonomic_nervous | 0.63527765 |
| 153 | MP0005464_abnormal_platelet_physiology | 0.63193386 |
| 154 | MP0001145_abnormal_male_reproductive | 0.62981148 |
| 155 | MP0001873_stomach_inflammation | 0.62673716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.45272683 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.84983609 |
| 3 | Reticulocytopenia (HP:0001896) | 5.12392338 |
| 4 | Macrocytic anemia (HP:0001972) | 4.12945326 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.99494277 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.99494277 |
| 7 | Pallor (HP:0000980) | 3.89899580 |
| 8 | Aplastic anemia (HP:0001915) | 3.83021909 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.60201800 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.57159095 |
| 11 | Thrombocytosis (HP:0001894) | 3.48457934 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.45889188 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.41012379 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.34043176 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.33104499 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.33104499 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.33104499 |
| 18 | Hepatic necrosis (HP:0002605) | 3.30179967 |
| 19 | Increased CSF lactate (HP:0002490) | 3.28837737 |
| 20 | Microretrognathia (HP:0000308) | 3.28121147 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27389547 |
| 22 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.22391470 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.22274375 |
| 24 | Increased serum lactate (HP:0002151) | 3.19525561 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.18476223 |
| 26 | Cellulitis (HP:0100658) | 3.17623460 |
| 27 | Oral leukoplakia (HP:0002745) | 3.12728810 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.12096732 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.06770880 |
| 30 | Increased hepatocellular lipid droplets (HP:0006565) | 3.03863214 |
| 31 | Exertional dyspnea (HP:0002875) | 3.01842191 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.95456139 |
| 33 | Obstructive lung disease (HP:0006536) | 2.94598514 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94598514 |
| 35 | Trismus (HP:0000211) | 2.94507970 |
| 36 | Abnormality of the anterior horn cell (HP:0006802) | 2.93584514 |
| 37 | Degeneration of anterior horn cells (HP:0002398) | 2.93584514 |
| 38 | Acute encephalopathy (HP:0006846) | 2.92597957 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 2.87053163 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86974441 |
| 41 | Increased muscle lipid content (HP:0009058) | 2.85180530 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.84882471 |
| 43 | Multiple enchondromatosis (HP:0005701) | 2.82005797 |
| 44 | Myopathic facies (HP:0002058) | 2.79857086 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.79383806 |
| 46 | Exercise-induced myalgia (HP:0003738) | 2.75123755 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.74928349 |
| 48 | Breast hypoplasia (HP:0003187) | 2.72100551 |
| 49 | Absent thumb (HP:0009777) | 2.71744121 |
| 50 | Colitis (HP:0002583) | 2.70717924 |
| 51 | Selective tooth agenesis (HP:0001592) | 2.70500406 |
| 52 | Lactic acidosis (HP:0003128) | 2.67287999 |
| 53 | Progressive muscle weakness (HP:0003323) | 2.64141753 |
| 54 | Exercise intolerance (HP:0003546) | 2.61523038 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.59284828 |
| 56 | Microvesicular hepatic steatosis (HP:0001414) | 2.58343154 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.57050093 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.54686977 |
| 59 | Achilles tendon contracture (HP:0001771) | 2.53284369 |
| 60 | Hypertensive crisis (HP:0100735) | 2.52625176 |
| 61 | Pancytopenia (HP:0001876) | 2.51689398 |
| 62 | IgM deficiency (HP:0002850) | 2.48450635 |
| 63 | Increased serum ferritin (HP:0003281) | 2.47330182 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.44444070 |
| 65 | Rough bone trabeculation (HP:0100670) | 2.44428086 |
| 66 | Respiratory difficulties (HP:0002880) | 2.44406006 |
| 67 | Abnormality of reticulocytes (HP:0004312) | 2.43568511 |
| 68 | Abnormality of macrophages (HP:0004311) | 2.43193547 |
| 69 | Carpal bone hypoplasia (HP:0001498) | 2.41428387 |
| 70 | Purpura (HP:0000979) | 2.41064753 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.36795810 |
| 72 | Emotional lability (HP:0000712) | 2.32975500 |
| 73 | Cerebral hypomyelination (HP:0006808) | 2.31254021 |
| 74 | Cerebral palsy (HP:0100021) | 2.31193957 |
| 75 | Polygenic inheritance (HP:0010982) | 2.30205817 |
| 76 | Poikiloderma (HP:0001029) | 2.28724928 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.28583486 |
| 78 | 11 pairs of ribs (HP:0000878) | 2.28254913 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.28128595 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25440979 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.24295693 |
| 82 | Meningitis (HP:0001287) | 2.22624642 |
| 83 | Poor head control (HP:0002421) | 2.22621250 |
| 84 | Respiratory failure (HP:0002878) | 2.22499379 |
| 85 | Muscle stiffness (HP:0003552) | 2.22314150 |
| 86 | Thoracic kyphosis (HP:0002942) | 2.21992423 |
| 87 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.21430844 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 2.20364369 |
| 89 | Patellar aplasia (HP:0006443) | 2.17898826 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.15920205 |
| 91 | Ragged-red muscle fibers (HP:0003200) | 2.15161042 |
| 92 | Basal cell carcinoma (HP:0002671) | 2.15095148 |
| 93 | Cerebral edema (HP:0002181) | 2.15011016 |
| 94 | Petechiae (HP:0000967) | 2.13984174 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 2.13186096 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 2.11207159 |
| 97 | J-shaped sella turcica (HP:0002680) | 2.11047555 |
| 98 | Amyloidosis (HP:0011034) | 2.09904217 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.09423052 |
| 100 | Inflammation of the large intestine (HP:0002037) | 2.09058394 |
| 101 | Recurrent viral infections (HP:0004429) | 2.08197171 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.05734673 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04556541 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04556541 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04556541 |
| 106 | Bulbar palsy (HP:0001283) | 2.04401040 |
| 107 | Premature graying of hair (HP:0002216) | 2.04323880 |
| 108 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03165895 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 2.02496751 |
| 110 | Cholecystitis (HP:0001082) | 2.02496751 |
| 111 | Hypertriglyceridemia (HP:0002155) | 2.02432950 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 2.01819774 |
| 113 | Premature ovarian failure (HP:0008209) | 2.01446348 |
| 114 | Axonal loss (HP:0003447) | 2.01442024 |
| 115 | Increased connective tissue (HP:0009025) | 2.00882142 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00317047 |
| 117 | Increased IgE level (HP:0003212) | 2.00156123 |
| 118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00081469 |
| 119 | Myoglobinuria (HP:0002913) | 1.99304718 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.99196487 |
| 121 | Abnormal hemoglobin (HP:0011902) | 1.97974291 |
| 122 | Secondary amenorrhea (HP:0000869) | 1.97891329 |
| 123 | Squamous cell carcinoma (HP:0002860) | 1.97253110 |
| 124 | CNS demyelination (HP:0007305) | 1.94856287 |
| 125 | Colon cancer (HP:0003003) | 1.94530555 |
| 126 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.94164613 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.93417546 |
| 128 | Hyperalaninemia (HP:0003348) | 1.93417546 |
| 129 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93417546 |
| 130 | Growth hormone excess (HP:0000845) | 1.93060747 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.92654469 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92366677 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 1.91730057 |
| 134 | Testicular atrophy (HP:0000029) | 1.91382343 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91101421 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.91101421 |
| 137 | Acute lymphatic leukemia (HP:0006721) | 1.89888679 |
| 138 | Panhypogammaglobulinemia (HP:0003139) | 1.87847317 |
| 139 | Bone marrow hypocellularity (HP:0005528) | 1.86650277 |
| 140 | Joint stiffness (HP:0001387) | 1.86509583 |
| 141 | Neoplasm of the pancreas (HP:0002894) | 1.86189831 |
| 142 | Abnormality of the thoracic spine (HP:0100711) | 1.85891089 |
| 143 | Recurrent fungal infections (HP:0002841) | 1.85686326 |
| 144 | Myelodysplasia (HP:0002863) | 1.84744473 |
| 145 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83598497 |
| 146 | Abnormality of the preputium (HP:0100587) | 1.83166132 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.81848344 |
| 148 | Redundant skin (HP:0001582) | 1.81804851 |
| 149 | Stridor (HP:0010307) | 1.81004238 |
| 150 | Abnormality of the ileum (HP:0001549) | 1.80621413 |
| 151 | Abnormal number of incisors (HP:0011064) | 1.80400023 |
| 152 | Muscle fiber atrophy (HP:0100295) | 1.80196777 |
| 153 | Abnormality of complement system (HP:0005339) | 1.80157867 |
| 154 | Cellular immunodeficiency (HP:0005374) | 1.79924472 |
| 155 | Upper motor neuron abnormality (HP:0002127) | 1.78783061 |
| 156 | Gastrointestinal stroma tumor (HP:0100723) | 1.77904262 |
| 157 | Pustule (HP:0200039) | 1.76987892 |
| 158 | Hyperacusis (HP:0010780) | 1.76535772 |
| 159 | Asplenia (HP:0001746) | 1.76416637 |
| 160 | Angiofibromas (HP:0010615) | 1.76344692 |
| 161 | Adenoma sebaceum (HP:0009720) | 1.76344692 |
| 162 | Dicarboxylic aciduria (HP:0003215) | 1.74536158 |
| 163 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74536158 |
| 164 | Slender long bone (HP:0003100) | 1.73610675 |
| 165 | Increased serum pyruvate (HP:0003542) | 1.72712683 |
| 166 | Abnormality of glycolysis (HP:0004366) | 1.72712683 |
| 167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72315418 |
| 168 | Broad distal phalanx of finger (HP:0009836) | 1.72151004 |
| 169 | Epistaxis (HP:0000421) | 1.72067054 |
| 170 | Loss of speech (HP:0002371) | 1.72018831 |
| 171 | Meckel diverticulum (HP:0002245) | 1.71253950 |
| 172 | Protrusio acetabuli (HP:0003179) | 1.71096244 |
| 173 | Rhabdomyolysis (HP:0003201) | 1.69377890 |
| 174 | Vacuolated lymphocytes (HP:0001922) | 1.68252405 |
| 175 | Myositis (HP:0100614) | 1.67903862 |
| 176 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.67468457 |
| 177 | Muscle fiber inclusion bodies (HP:0100299) | 1.67419430 |
| 178 | Seborrheic dermatitis (HP:0001051) | 1.67228339 |
| 179 | Cleft eyelid (HP:0000625) | 1.67004842 |
| 180 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.65983457 |
| 181 | Hypoplasia of the radius (HP:0002984) | 1.64549925 |
| 182 | Abnormality of T cell physiology (HP:0011840) | 1.64149927 |
| 183 | Hypoplasia of the pons (HP:0012110) | 1.63537028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.35376244 |
| 2 | BUB1 | 4.27965263 |
| 3 | WEE1 | 3.12004627 |
| 4 | EIF2AK1 | 2.78861604 |
| 5 | CDC7 | 2.53772202 |
| 6 | BCKDK | 2.50424560 |
| 7 | PRPF4B | 2.41563750 |
| 8 | TESK2 | 2.26095404 |
| 9 | NEK2 | 2.23862522 |
| 10 | TLK1 | 2.14668520 |
| 11 | SMG1 | 2.14552976 |
| 12 | IRAK3 | 2.13109129 |
| 13 | MAP3K11 | 2.04810472 |
| 14 | MAP3K10 | 2.04717716 |
| 15 | CDK19 | 2.04514251 |
| 16 | MAP4K1 | 1.94316267 |
| 17 | VRK2 | 1.89914804 |
| 18 | STK16 | 1.86766538 |
| 19 | PIM2 | 1.85561092 |
| 20 | SRPK1 | 1.74742914 |
| 21 | SCYL2 | 1.71316190 |
| 22 | KDR | 1.70241301 |
| 23 | BLK | 1.67548796 |
| 24 | DYRK3 | 1.67169903 |
| 25 | GRK6 | 1.65829598 |
| 26 | EIF2AK3 | 1.62995985 |
| 27 | BRSK2 | 1.61299583 |
| 28 | RPS6KA4 | 1.60586638 |
| 29 | PASK | 1.58724731 |
| 30 | RIPK4 | 1.50702033 |
| 31 | PLK1 | 1.49614606 |
| 32 | PKN2 | 1.46816653 |
| 33 | VRK1 | 1.35282731 |
| 34 | TTN | 1.34714892 |
| 35 | FLT3 | 1.34072026 |
| 36 | NME1 | 1.32882695 |
| 37 | MAP2K3 | 1.32276868 |
| 38 | CDK7 | 1.30863921 |
| 39 | AURKA | 1.30801371 |
| 40 | MAP3K13 | 1.29416043 |
| 41 | PAK4 | 1.28934701 |
| 42 | AURKB | 1.28930176 |
| 43 | RPS6KB2 | 1.28844506 |
| 44 | ERN1 | 1.26380295 |
| 45 | PLK4 | 1.22088148 |
| 46 | MAPKAPK3 | 1.21440837 |
| 47 | CCNB1 | 1.20315201 |
| 48 | BRSK1 | 1.20002375 |
| 49 | MAP3K1 | 1.15850008 |
| 50 | TRIB3 | 1.15047668 |
| 51 | ZAP70 | 1.13040247 |
| 52 | SIK1 | 1.11053345 |
| 53 | ACVR1B | 1.10228706 |
| 54 | FES | 1.09782719 |
| 55 | LRRK2 | 1.07169505 |
| 56 | MAP3K8 | 1.06870524 |
| 57 | MKNK1 | 1.06555245 |
| 58 | MAP3K3 | 1.05905999 |
| 59 | CDK4 | 1.05621435 |
| 60 | TTK | 1.05107024 |
| 61 | LIMK1 | 1.04440016 |
| 62 | DAPK1 | 1.02834339 |
| 63 | TSSK6 | 0.99355965 |
| 64 | ATR | 0.98887782 |
| 65 | NEK1 | 0.98581613 |
| 66 | CDK8 | 0.97137093 |
| 67 | ICK | 0.96121151 |
| 68 | MKNK2 | 0.95711656 |
| 69 | KIT | 0.90569344 |
| 70 | BRAF | 0.90427273 |
| 71 | RIPK1 | 0.90332444 |
| 72 | BTK | 0.87120051 |
| 73 | EEF2K | 0.84441275 |
| 74 | CHEK2 | 0.82946231 |
| 75 | PIM1 | 0.82656701 |
| 76 | CSF1R | 0.80275369 |
| 77 | ILK | 0.79859865 |
| 78 | MOS | 0.78986165 |
| 79 | CSNK2A2 | 0.77215287 |
| 80 | PDPK1 | 0.75833713 |
| 81 | CSNK2A1 | 0.74854181 |
| 82 | MAPK12 | 0.74507066 |
| 83 | STK10 | 0.73229042 |
| 84 | TNK2 | 0.71964764 |
| 85 | TESK1 | 0.71690416 |
| 86 | MAPK11 | 0.68762011 |
| 87 | JAK3 | 0.68083048 |
| 88 | PAK1 | 0.67360606 |
| 89 | MAP2K6 | 0.64242802 |
| 90 | TEC | 0.63619868 |
| 91 | EPHA2 | 0.62947947 |
| 92 | ARAF | 0.61008708 |
| 93 | TYK2 | 0.59829229 |
| 94 | IKBKB | 0.57914596 |
| 95 | PRKD3 | 0.55847078 |
| 96 | CHEK1 | 0.55517483 |
| 97 | STK4 | 0.55184872 |
| 98 | AKT2 | 0.54823221 |
| 99 | TGFBR1 | 0.53240489 |
| 100 | TBK1 | 0.52787248 |
| 101 | PRKG2 | 0.52712168 |
| 102 | SYK | 0.52690501 |
| 103 | MAP3K14 | 0.52642884 |
| 104 | TAOK2 | 0.52359625 |
| 105 | RPS6KA2 | 0.52121541 |
| 106 | IKBKE | 0.51323572 |
| 107 | PLK3 | 0.50656838 |
| 108 | CDK2 | 0.49806388 |
| 109 | RPS6KA6 | 0.49502379 |
| 110 | HIPK2 | 0.49003436 |
| 111 | PRKCI | 0.48598820 |
| 112 | RPS6KC1 | 0.48410869 |
| 113 | RPS6KL1 | 0.48410869 |
| 114 | CSK | 0.47905208 |
| 115 | PRKD2 | 0.47878880 |
| 116 | CAMKK1 | 0.46591641 |
| 117 | PDK1 | 0.46420338 |
| 118 | MATK | 0.45808549 |
| 119 | CDC42BPA | 0.44794910 |
| 120 | PTK6 | 0.43668878 |
| 121 | TGFBR2 | 0.43217096 |
| 122 | ABL2 | 0.43180440 |
| 123 | BMX | 0.43074097 |
| 124 | IRAK2 | 0.42919835 |
| 125 | MAP3K12 | 0.41082713 |
| 126 | DAPK3 | 0.40473408 |
| 127 | MYLK | 0.40172742 |
| 128 | CAMK2G | 0.40009907 |
| 129 | LYN | 0.38885955 |
| 130 | RAF1 | 0.38856234 |
| 131 | MARK3 | 0.36146164 |
| 132 | ITK | 0.35177218 |
| 133 | HCK | 0.35172654 |
| 134 | RPS6KA5 | 0.34141124 |
| 135 | MAP2K2 | 0.33497991 |
| 136 | LCK | 0.33283874 |
| 137 | FGFR4 | 0.32309605 |
| 138 | MAPKAPK2 | 0.31861200 |
| 139 | IRAK4 | 0.28958436 |
| 140 | MAPK4 | 0.28940508 |
| 141 | EIF2AK2 | 0.28938430 |
| 142 | TAOK1 | 0.26951023 |
| 143 | ATM | 0.26414275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.52118562 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.63800389 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.93164565 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.76832123 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.11891019 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 3.07674784 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.05017323 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.93612830 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.60888420 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.60090021 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.39495118 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.39217585 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.20802586 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18529167 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.16711606 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.09388056 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.88371225 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.87806451 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.84842903 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.74659033 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73881037 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70093810 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67613322 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54201803 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.50088890 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47155401 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45794021 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.43656450 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.40260079 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38322748 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34929114 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31614205 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28293550 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25915697 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23560357 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22818262 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.22564449 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19666803 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18037410 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17502033 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15621864 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.14692499 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14268887 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.12533813 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10389011 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08153099 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07981592 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06836390 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.06733712 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04625648 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.04267337 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02869509 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02508263 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01804546 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96244405 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96074832 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93193680 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.92551030 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91725356 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90214512 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90048997 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81968327 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80496830 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78449972 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77200368 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75863328 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75859769 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72342702 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72284278 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72103697 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71780014 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71009258 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70546849 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69536338 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69305058 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69088481 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68600516 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67439396 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67326403 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65419721 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64787849 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62546581 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.62286561 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61012556 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60512813 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60105811 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.59696097 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58546711 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56830646 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55638855 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54064678 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53899830 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.53817673 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.52547652 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51748161 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51168273 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49432042 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49070658 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47460684 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47459154 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46743857 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.46439200 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46243053 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.46133362 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45686202 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45075686 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44852347 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43149275 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40510453 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40272793 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39541730 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38064726 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37202455 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35704342 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33655560 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.33143698 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30611747 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30482429 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.29844588 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29453151 |
| 121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23852909 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18348892 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17499871 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16387607 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14080010 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12235460 |
| 127 | Measles_Homo sapiens_hsa05162 | 0.11961587 |
| 128 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11519490 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10311935 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.10113090 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08331548 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.07550905 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.06326142 |
| 134 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.06288720 |
| 135 | Peroxisome_Homo sapiens_hsa04146 | 0.05542251 |
| 136 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.05521179 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.04546834 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.00939834 |
| 139 | Influenza A_Homo sapiens_hsa05164 | 0.00407008 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.00184960 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0224583 |

